Ini Buktinya Ayu Tingting Tampak Lebih ABG Dari Nagita, Fans Sini Liatlah kalau Gak Percaya!!


Sodium glucose co-transporter 2 (SGLT2) inhibitor drugs are a new class of diabetes treatment commonly referred to as sodium-glucose inhibitors. There are many drugs found in this category. This new drug class facilitates glucose re-absorption in the kidneys and increases excretion of blood glucose in the patient's urine. Many people experience weight loss management and reduce hypoglycemia using sodium glucose inhibitors. They may also reduce blood pressure. This class of diabetes medicine received a warning from the U.S. Food and Drug Administration (FDA). This medicine is taken once daily to lower AC1 or blood sugar levels. Sodium glucose inhibitor drugs are manufactured by many pharmacology companies. This new type of medicine works well for many diabetics. This could be younger and healthier patients. The age and general health of the patient influences the number and type of negative reactions. Older patients may experience more severe symptoms. The medicine's stated side effects include genital fungal infections, increased LDL, increased urination, higher rates of urinary tract infections, dehydration, fractures, and low blood pressure. There is also a risk of bladder cancer. The fractures could appear after as little as three months of the drug. It also reduced bone density along the spine and hip area. The FDA notice states that sodium glucose inhibitors for type 2 diabetes known as may lead to ketoacidosis. Warning signs for high levels of ketones in the blood include trouble breathing, abdominal pain, vomiting, nausea, confusion, and extreme fatigue. This is a serious condition which damages the kidneys and causes high levels of blood acids or ketones in the body. The skin area covering the kidneys and liver may be inflamed and painful. This can result in heart attacks, kidney failure, ketosis, or death. Patients with liver and kidney problems should avoid this medication. An issue for any drug's warnings is based upon the length of the clinical trials used for the FDA drug multi stage approval process. Many symptoms may not surface until after the drug has been taken for a longer time period than the duration of the clinical trial. The average monthly price for this class of medication is approximately $400 per month. This high price creates issues for older people on social security or fixed incomes. Online information states that the wholesale price of the drug is $8.77 a pill, leading to pricing without co-pays or coverage about $11.40 a pill. It can found online at Targets and other retail drugstores for about $379 a month. These medicines can be located for those without health insurance. Some doctors offer free samples. Due to the high cost of this medicine, many people may have difficulty affording sodium glucose inhibitors. The medicine is part of a prescription assistance plan delivering pricing of 4 months free followed by up to one year of $5 per month. The Partnership for Prescription Assistance helps qualifying people without prescription drug coverage to access free or almost free medicines. Another similar program delivering low-cost or free drugs includes RX Hope. People on Medicaid, Medicare, federal and state healthcare plans, or Tricare are excluded from free and affordable price offers by several drug firms. Article Source: